The clinical role of perfusion-weighted MRI (PWI) in head and neck squamous cell carcinoma (HNSCC) remains to be defined. The aim of this study was to provide evidence-based recommendations for the use of PWI sequence in HNSCC with regard to clinical indications and acquisition parameters.
Clinical indications and acquisition protocol for the use of dynamic contrast-enhanced MRI in head and neck cancer squamous cell carcinoma: recommendations from an expert panel / Romeo, V., Stanzione, A., Ugga, L., Cuocolo, R., Cocozza, S., Quarantelli, M., Chawla, S., Farina, D., Golay, X., Parker, G., Shukla-Dave, A., Thoeny, H., Vidiri, A., Brunetti, A., Surlan-Popovic, K., Bisdas, S.. - In: INSIGHTS INTO IMAGING. - ISSN 1869-4101. - 13:1(2022), p. 198. [10.1186/s13244-022-01317-1]
Clinical indications and acquisition protocol for the use of dynamic contrast-enhanced MRI in head and neck cancer squamous cell carcinoma: recommendations from an expert panel
Romeo, Valeria;Stanzione, Arnaldo;Ugga, Lorenzo;Cuocolo, Renato;Cocozza, Sirio;Brunetti, Arturo;
2022
Abstract
The clinical role of perfusion-weighted MRI (PWI) in head and neck squamous cell carcinoma (HNSCC) remains to be defined. The aim of this study was to provide evidence-based recommendations for the use of PWI sequence in HNSCC with regard to clinical indications and acquisition parameters.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
